PARI Pharma GmbH
Medical Technology
-
Short facts
-
- Research & Development
- Year founded not available
- Employees (site): not available
- Turnover: not available
Products/services: Aerosol delivery systems; Development and commercialization of optimizes drug and device combinations
Basic data
Company
PARI Pharma GmbH
Street
Moosstr. 3
PC / City
82319 Starnberg
County
Upper Bavaria
Phone
+49 89 742846-0
Fax
+49 89 74284630
Homepage
Language skills
English, French, German
Profile/competences
Core competencies
PARI Pharma is developing a portfolio of inhalable drugs to treat respiratory diseases such as cystic fibrosis, bronchiolitis obliterans, asthma, and COPD as well as rhinosinusitis. The company is focusing on improving the therapeutic efficiency of existing treatments by combining PARI Pharma?s proprietary eFlow Technology Nebulizer Systems with in-house formulation development and optimization know-how. Goal is to maximize treatment efficiency and simultaneously minimize the treatment time to ultimately improve patient compliance. Besides the company?s proprietary drug development programs, PARI Pharma partners with selected pharma and biotech companies to develop new and improved therapies based on the partner?s proprietary compounds and PARI Pharma?s eFlow Technology Nebulizer Systems.
Key sectors / sub-sectors
- Medical Technology: Anesthesia, respiration, resuscitation
Certifications
- GMP
- ISO 13485
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available